Borderline Ovarian Epithelial Tumor Completed Phase 1 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0078954 (Borderline Ovarian Epithelial Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02520115Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerTreatment